Altiratinib blocks Toxoplasma gondii and Plasmodium falciparum development by selectively targeting a kinase critical for splicing.
Swale C@, Bellini V, Matthew W. Bowler, Nardella Flore, Marie-Pierre Brenier-Pinchart, Dominique Cannella, Lucid Belmudes,…
Science Translational Medicine 2022 These authors contributed equally: Christopher Swale, Bellini Valeria